Yuquan Wei Selected Research

Yuquan Wei Research Topics

Disease

241	Neoplasms (Cancer) 09/2022 - 06/2004
42	Neoplasm Metastasis (Metastasis) 06/2022 - 04/2008
37	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 12/2005
27	Carcinoma (Carcinomatosis) 01/2018 - 09/2005
23	Inflammation (Inflammations) 01/2021 - 06/2005
21	Breast Neoplasms (Breast Cancer) 03/2020 - 09/2005
20	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 07/2006
19	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2005
16	Colonic Neoplasms (Colon Cancer) 01/2020 - 12/2004
13	Carcinogenesis 01/2022 - 06/2009
13	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 12/2004
9	Infections 09/2022 - 01/2013
9	Melanoma (Melanoma, Malignant) 06/2022 - 01/2011
9	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 01/2009
7	Necrosis 10/2021 - 01/2013
7	Glioma (Gliomas) 01/2018 - 06/2009
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 11/2010
5	Fibrosis (Cirrhosis) 01/2022 - 12/2014
5	Bites and Stings (Sting) 10/2020 - 01/2016
5	Hypoxia (Hypoxemia) 01/2019 - 01/2009
5	Arthritis (Polyarthritis) 01/2018 - 11/2010
5	Body Weight (Weight, Body) 09/2016 - 11/2010
5	Lymphatic Metastasis 07/2016 - 06/2007
5	Lewis Lung Carcinoma 01/2016 - 09/2009
5	Stomach Neoplasms (Stomach Cancer) 10/2014 - 01/2009
4	Hypertension (High Blood Pressure) 09/2022 - 06/2009
4	Leukemia 11/2021 - 01/2008
4	Wounds and Injuries (Trauma) 07/2021 - 12/2011
4	Pneumonia (Pneumonitis) 01/2021 - 12/2014
4	Atherosclerosis 01/2021 - 06/2012
4	Mitochondrial Diseases (Mitochondrial Disease) 11/2019 - 04/2017

Drug/Important Bio-Agent (IBA)

64	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2004
27	VaccinesIBA 01/2022 - 12/2004
27	Pharmaceutical PreparationsIBA 01/2019 - 02/2010
23	Liposomes (Liposome)IBA 01/2022 - 01/2008
22	CytokinesIBA 07/2021 - 04/2008
19	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 12/2005
17	MicellesIBA 10/2018 - 04/2011
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 12/2004
16	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2009
12	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2006
12	Biological ProductsIBA 12/2019 - 09/2006
11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2008
11	Cancer VaccinesIBA 01/2022 - 12/2004
11	Therapeutic UsesIBA 01/2021 - 01/2014
10	Peptides (Polypeptides)IBA 01/2022 - 12/2004
10	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 07/2009
10	EnzymesIBA 01/2021 - 08/2010
10	AntigensIBA 01/2021 - 11/2008
10	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 08/2008
10	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 08/2010
10	PolyethyleneimineIBA 09/2017 - 01/2011
9	Heparin (Liquaemin)FDA LinkGeneric 09/2017 - 01/2011
8	NanogelsIBA 09/2017 - 07/2011
8	honokiolIBA 08/2011 - 01/2008
7	AntibodiesIBA 10/2020 - 10/2013
7	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 06/2012
7	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 05/2013
7	AlginatesIBA 09/2017 - 07/2011
7	methoxy poly(ethylene glycol-co-epsilon-caprolactone)IBA 09/2017 - 06/2011
7	CateninsIBA 02/2017 - 12/2013
7	CholesterolIBA 01/2017 - 04/2011
7	Ethylene Glycol (Monoethylene Glycol)IBA 01/2014 - 04/2011
6	CollagenIBA 01/2022 - 01/2011
6	LigandsIBA 10/2021 - 01/2012
6	Messenger RNA (mRNA)IBA 01/2020 - 04/2009
6	SurvivinIBA 01/2019 - 06/2010
6	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 01/2018 - 05/2009
5	Histones (Histone)IBA 01/2022 - 08/2017
5	AntioxidantsIBA 11/2021 - 09/2005
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2011
5	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
5	Monoclonal AntibodiesIBA 11/2020 - 11/2014
5	Phosphotransferases (Kinase)IBA 01/2019 - 01/2009
5	LipidsIBA 09/2016 - 08/2011
5	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2015 - 07/2010
5	Caspase 3 (Caspase-3)IBA 05/2014 - 09/2005
5	caprolactoneIBA 01/2014 - 06/2011
5	QuercetinIBA 12/2013 - 04/2009
5	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 06/2013 - 10/2010
4	Interleukin-27 (Interleukin 27)IBA 01/2022 - 05/2013
4	MethyltransferasesIBA 01/2022 - 02/2016
4	CaspasesIBA 10/2021 - 05/2014
4	Tyrosine Kinase InhibitorsIBA 07/2021 - 12/2011
4	Dinoprostone (PGE2)FDA Link 04/2020 - 05/2013
4	Interleukin-15 (Interleukin 15)IBA 01/2020 - 07/2011
4	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2016
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 01/2014
4	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 01/2020 - 07/2013
4	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2014
4	Long Noncoding RNAIBA 01/2019 - 01/2017
4	Indicators and Reagents (Reagents)IBA 01/2019 - 05/2015
4	ErbB Receptors (EGF Receptor)IBA 12/2018 - 05/2005
4	Interleukin-12 (IL 12)IBA 10/2018 - 04/2008

Therapy/Procedure

107	Therapeutics 03/2022 - 06/2004
26	Immunotherapy 01/2022 - 06/2004
22	Drug Therapy (Chemotherapy) 12/2021 - 11/2008
11	Oral Administration 01/2019 - 09/2006
9	Radiotherapy 01/2021 - 04/2010
5	Aftercare (After-Treatment) 01/2018 - 09/2005